open access

Vol 66, No 4 (2015)
Postgraduate education
Published online: 2015-09-01
Submitted: 2015-01-25
Accepted: 2015-02-16
Get Citation

GO-QOL — disease-specific quality of life questionnaire in Graves’ orbitopathy

Nadia Sawicka-Gutaj, Tomasz Bednarczuk, Jacek Daroszewski, Joanna Waligórska-Stachura, Piotr Miśkiewicz, Jerzy Sowiński, Marek Bolanowski, Marek Ruchała
DOI: 10.5603/EP.2015.0046
·
Endokrynologia Polska 2015;66(4):362-366.

open access

Vol 66, No 4 (2015)
Postgraduate education
Published online: 2015-09-01
Submitted: 2015-01-25
Accepted: 2015-02-16

Abstract

The main goal of therapy for Graves’ orbitopathy (GO) is to restore visual function and to improve quality of life (QOL); therefore, the idea of self-assessment of eye changes by the patient has been developed. We developed a validated Polish version of the GO-QOL questionnaire (GO-QOLpl). As an original version we used the English version of GO-QOL, which consists of 15 questions summarised in two subscales. GO-QOLpl was translated and validated in accordance with standard principles for translation of patient-reported outcomes (PRO). GO-QOLpl is a linguistically validated version of the original GO-QOL questionnaire, which is recommended by the European Group of Graves’ Orbitopathy (EUGOGO). We strongly support the use of GO-QOLpl for the assessment of QOL among Polish patients with GO in clinical practice. (Endokrynol Pol 2015; 66 (4): 362–366)

Abstract

The main goal of therapy for Graves’ orbitopathy (GO) is to restore visual function and to improve quality of life (QOL); therefore, the idea of self-assessment of eye changes by the patient has been developed. We developed a validated Polish version of the GO-QOL questionnaire (GO-QOLpl). As an original version we used the English version of GO-QOL, which consists of 15 questions summarised in two subscales. GO-QOLpl was translated and validated in accordance with standard principles for translation of patient-reported outcomes (PRO). GO-QOLpl is a linguistically validated version of the original GO-QOL questionnaire, which is recommended by the European Group of Graves’ Orbitopathy (EUGOGO). We strongly support the use of GO-QOLpl for the assessment of QOL among Polish patients with GO in clinical practice. (Endokrynol Pol 2015; 66 (4): 362–366)

Get Citation

Keywords

quality of life; Graves’ orbitopathy; thyroid associated ophthalmopathy; Graves’ disease; autoimmune thyroid diseases

About this article
Title

GO-QOL — disease-specific quality of life questionnaire in Graves’ orbitopathy

Journal

Endokrynologia Polska

Issue

Vol 66, No 4 (2015)

Pages

362-366

Published online

2015-09-01

DOI

10.5603/EP.2015.0046

Bibliographic record

Endokrynologia Polska 2015;66(4):362-366.

Keywords

quality of life
Graves’ orbitopathy
thyroid associated ophthalmopathy
Graves’ disease
autoimmune thyroid diseases

Authors

Nadia Sawicka-Gutaj
Tomasz Bednarczuk
Jacek Daroszewski
Joanna Waligórska-Stachura
Piotr Miśkiewicz
Jerzy Sowiński
Marek Bolanowski
Marek Ruchała

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl